StockData
Maravai LifeSciences Holdings, Inc. logo

Maravai LifeSciences Holdings, Inc. (MRVI) stock

MRVINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30170% above fair value
$7.38+0.10 (+1.37%)

Close on Nov 18, 2026Market cap $1.92BP/E –Yield –

Maravai LifeSciences pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Maravai LifeSciences's pe ratio was 116.0× on Jan 31, 2024, against 9.2× a year earlier. Over the last 2 years it ranged from 8.3× to 131.0×, with a median of 15.6×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2024Jan 31, 2024116.0×−15.0
2023Dec 29, 2023131.0×+122.0
2022Dec 30, 20229.0×–

More Maravai LifeSciences figures

See a number that looks wrong?